Keep the study coordinated from visit to visit.

Agree a workable oversight plan

Map the study calendar, responsible team, critical procedures and decision points. Specify reporting formats, communication cadence and how site issues reach the sponsor. A structured oversight plan should reflect the actual risks and available resources.

Scope monitoring and site coordination

Agree the tasks and authorized access needed for the proposed study.

• Qualification, initiation, monitoring and close-out visits
• Remote review where permitted and appropriate
• Site communication and action-item follow-up
• Protocol-deviation assessment and escalation
• Training and essential-document tracking
• Coordination with approved vendors and laboratories

Separate monitoring from clinical judgment

Monitors assess conduct and records against the protocol and applicable requirements. The investigator remains responsible for trial-related medical decisions and participant care. Safety coordination supports the agreed reporting process; it does not replace sponsor medical assessment or licensed clinical care.

Resolve findings and hand over clearly

Record each finding, its impact, owner, due date and evidence of resolution. Escalate significant risks promptly. At close-out, reconcile pending issues, data queries, products and records, and identify the contacts responsible for later reporting and retention.